Connect with us

Hi, what are you looking for?

Thursday, Apr 18, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

The weed wire

Supreme Cannabis delays product rollout amid COVID-19 pandemic

Company also completes first international shipment to Israel

Supreme Cannabis delays product rollout amid COVID-19 pandemic
Supreme Cannabis delays product rollout amid COVID-19 pandemic

The Supreme Cannabis Company, Inc. (TSX: FIRE, OTCQX: SPRFW) announced Tuesday it was delaying the launch of two products due to “minor” business setbacks caused by COVID-19.

The 7ACRES’ whole flower pre-rolls and PAX pods for the PAX Era vaporizer were slated to launch in the company’s third quarter, which ended March 31, 2020, but are now planned to launch in fiscal Q4.

These delays are caused by supplier and third-party testing disruptions, Supreme said in a press release.

Read more: Former Starbucks president Colin Moore named Supreme Cannabis interim CEO

Read more: Supreme Cannabis acquires Toronto-based Truverra for $20 million

During the coronavirus pandemic, Supreme said it will give its front-line employees a pay raise to thank them for their hard work.

To mitigate risk the company said it is encouraging employees to work remotely whenever possible and is spacing out employees the best it can. Shift sizes are being limited, time between shifts is being stretched, breaks are being staggered and everyone is being given masks and gloves.

The company also completed its first international cannabis shipment to Breath of Life International, Ltd., Israel’s largest producer of medical cannabis, Supreme said. This partnership will allow BOL Pharma to sell Truverra-branded medical cannabis to medical cannabis patients in Israel.

“With the support of BOL Pharma, we navigated both Canada and Israel’s complex regulatory landscapes to achieve compliance with regulatory authorities in both countries, including Health Canada, the Canadian Food Inspection Agency and Israel’s Ministry of Health and Ministry of Agriculture and Rural Development,” Supreme interim president and CEO Colin Moore said.

Truverra cannabis is grown at Supreme’s 440,000 square foot facility in Kincardine, Ontario.

Israeli medical cannabis patients gained access to Truverra products March 30, and the company is already receiving positive feedback from patients, BOL Pharma CEO Tamir Gedo said.

Top image via The Supreme Cannabis Company


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


U.S. Coast Guard declares fire out on Genius Star XI; Crew safe, investigation into origins under way


The $10M shipment follows an $8M export made last July


Some of the funds will go toward expanding its digital retail platform


Amid a wave of consolidation, the Ottawa firm says the deal will give it a top-2 position in the Canadian adult-use weed market